N-氧代煙酰胺
| 中文名稱 | N-氧代煙酰胺 |
|---|---|
| 中文同義詞 | N-氧化煙酰胺;煙堿-N-氧化物;N-氧代煙酰胺;煙酰胺-N-氧化物;煙酰胺氮氧化物;煙堿-N-氧化物,98%;煙酰胺-N-氧化物 N-氧代煙酰胺;尼克酰胺N氧化物 |
| 英文名稱 | Nicotinamide-N-oxide |
| 英文同義詞 | 1-OXY-NICOTINAMIDE;3-(AMINOCARBONYL)PYRIDINIUM-1-OLATE;AKOS 94294;NICOTINAMIDE 1-OXIDE;TIMTEC-BB SBB004187;3-Pyridinecarboxamide, 1-oxide;3-Pyridinecarboxamide,1-oxide(9CI);1-Oxidopyridin-1-ium-3-carboxamide |
| CAS號 | 1986-81-8 |
| 分子式 | C6H6N2O2 |
| 分子量 | 138.12 |
| EINECS號 | 217-859-4 |
| 相關(guān)類別 | 生化試劑;醫(yī)藥中間體;核苷,核苷酸,寡核苷酸;小分子抑制劑;無機(jī)化工原料;其他原料;有機(jī)中間體;生化試劑-維生素;有機(jī)化工原料;AMIDE;Biochemicals and Reagents;NAD and Analogs;Nucleosides, Nucleotides, Oligonucleotides;Amines;Bases & Related Reagents;Heterocycles;Metabolites & Impurities;Nicotine Derivatives;Nucleotides;Amines, Heterocycles, Metabolites & Impurities, Nicotine Derivatives, Nucleotides, Bases & Related Reagents;雜質(zhì)對照品;合成材料中間體 |
| Mol文件 | 1986-81-8.mol |
| 結(jié)構(gòu)式 | ![]() |
N-氧代煙酰胺 性質(zhì)
| 熔點(diǎn) | 291-293 °C (dec.)(lit.) |
|---|---|
| 沸點(diǎn) | 253.51°C (rough estimate) |
| 密度 | 1.3471 (rough estimate) |
| 折射率 | 1.5100 (estimate) |
| 儲存條件 | Inert atmosphere,Room Temperature |
| 溶解度 | 可溶于DMSO(略微加熱)、甲醇(略微加熱) |
| 形態(tài) | 固體 |
| 酸度系數(shù)(pKa) | 14.38±0.50(Predicted) |
| 顏色 | 白色至類白色 |
| 敏感性 | Hygroscopic |
| 主要應(yīng)用 | 藥物小分子 |
| InChI | 1S/C6H6N2O2/c7-6(9)5-2-1-3-8(10)4-5/h1-4H,(H2,7,9) |
| InChIKey | USSFUVKEHXDAPM-UHFFFAOYSA-N |
| SMILES | NC(=O)c1ccc[n+]([O-])c1 |
| CAS 數(shù)據(jù)庫 | 1986-81-8(CAS DataBase Reference) |
|
CXCR2
|
Human Endogenous Metabolite
|
Nicotinamide is one of the forms of vitamin B 3 . It is a precursor for nicotinamide adenine dinucleotide, which is best known as an electron carrier in oxidative phosphorylation and as a cofactor for many dehydrogenases. It is metabolized through two enzymatic systems. The first system starts with the methylation of nicotinamide by nicotinamide N-methyltransferase, which can subsequently be oxidized by aldehyde oxidase. The second enzymatic system oxidizes nicotinamide to nicotinamide N-oxide. A series of nicotinamide N-oxides is synthesized and shown to be novel, potent, and selective antagonists of the CXCR2 receptor. Compound 1 has demonstrated potent inhibition of neutrophil chemotaxis (IC 50 =10 nM). Compound 2 is a selective antagonist of IL-8 binding (IC 50 =110 nM) and potent inhibitor of neutrophil chemotaxis (IC 50 =170 nM).
安全信息
| 提供商 | 語言 |
|---|---|
|
英文
|
|
|
英文
|
|
|
英文
|
